organoids

R&D

Organoid-based approaches may become an integral part of neurological safety testing, offering a clearer view of risk.

R&D

While support for reducing animal use has never been stronger, the path to broad adoption is steep and complex.

News

The UK government has set out an ambitious plan to phase out animal testing in scientific studies within five years.

R&D

On the emergence of brain organoids and the advent of automation, the latter being essential for high-throughput approaches drug development demands.

R&D

Adityo Prakash, founder and CEO of Verseon, discusses small datasets, real-world scenarios, and organoids.

R&D

Hydrogels are revolutionising cell therapy storage – discover how they tackle cold chain challenges and reduce costs while preserving cell viability.